Cargando…
A bioconjugate vaccine against Brucella abortus produced by engineered Escherichia coli
Brucellosis, mainly caused by Brucella, is a widespread zoonotic disease worldwide, with no available effective vaccine for human use. Recently, bioconjugate vaccines against Brucella have been prepared in Yersinia enterocolitica O:9 (YeO9), whose O-antigen structure is similar to that of Brucella a...
Autores principales: | Li, Shulei, Huang, Jing, Wang, Kangfeng, Liu, Yan, Guo, Yan, Li, Xiang, Wu, Jun, Sun, Peng, Wang, Yufei, Zhu, Li, Wang, Hengliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9995886/ https://www.ncbi.nlm.nih.gov/pubmed/36911199 http://dx.doi.org/10.3389/fbioe.2023.1121074 |
Ejemplares similares
-
A Label-Based Polymer Nanoparticles Biosensor Combined with Loop-Mediated Isothermal Amplification for Rapid, Sensitive, and Highly Specific Identification of Brucella abortus
por: Yang, Xinggui, et al.
Publicado: (2021) -
Glucose-Derived Raspberry Ketone Produced via Engineered Escherichia coli Metabolism
por: Masuo, Shunsuke, et al.
Publicado: (2022) -
Genetic Engineering of Klebsiella pneumoniae ATCC 25955 for Bioconjugate Vaccine Applications
por: Liu, Yan, et al.
Publicado: (2023) -
Enhancement of Immune Response of Bioconjugate Nanovaccine by Loading of CpG through Click Chemistry
por: Mo, Mengting, et al.
Publicado: (2023) -
Engineering Escherichia coli for diagnosis and management of hyperuricemia
por: Gencer, Gozde, et al.
Publicado: (2023)